The American Academy of Pain Medicine

> Log-in
Join AAPM

Welcome

The American Academy of Pain Medicine (AAPM) is the medical specialty society representing physicians practicing in the field of Pain Medicine. As a medical specialty society, the Academy is involved in education, training, advocacy, and research in the specialty of Pain Medicine.

The practice of Pain Medicine is multi-disciplinary in approach, incorporating modalities from various specialties to ensure the comprehensive evaluation and treatment of the pain patient. AAPM represents the diverse scope of the field through membership from a variety of origins, including such specialties as anesthesiology, internal medicine, neurology, neurological surgery, orthopedic surgery, physiatry, and psychiatry.

Pain News

2008-07-18 | Medscape
Methylnaltrexone: Relief for Opiate-Induced Constipation
One of the most troubling side effects of opioid analgesia is constipation. Laxative therapy is rarely completely effective. Patients are often left with the unwelcome choice of living with pain from the underlying disease process or living with the discomfort of constipation, both challenges to the quality..
2008-07-17 | U-Wire.com
USF researchers: Smokers light up after pain
A new study has demonstrated that pain can increase the desire to smoke cigarettes. The study, conducted by researchers from USF and the H. Lee Moffitt Cancer Center and Research Institute, could have important implications for smokers who suffer from chronic pain.
2008-07-16 | Newswise
Defining the Urologic Chronic Pelvic Pain Syndromes: A New Beginning
UROLOGY, CHRONIC PELVIC PAIN, INTERSTITIAL CYSTITIS, PROSTATITIS, PAINFUL BLADDER, IC/PBS, NIDDK Contact Information Available for logged-in reporters only Description A group of international experts in urology, gastroenterology, internal medicine, rheumatology, epidemiology, behavioral science and other...
2008-07-16 | MedicineNet.com
Hip, Knee Replacements Do Ease Symptoms
TUESDAY, July 15 (HealthDay News) Undergoing hip or joint replacement surgery may well be worth the trouble for older adults with severe osteoarthritis, researchers say.
2008-07-16 | Journal of Neuroscience
Presynaptic and Postsynaptic Amplifications of Neuropathic Pain in the Anterior Cingulate Cortex
__ __ 2008-07-16 17:33:00 Presynaptic and Postsynaptic Amplifications of Neuropathic Pain in the Anterior Cingulate Cortex...
2008-07-16 | Calibre Macro World
SRI International Research Sheds Light on Fight-or-Flight Response
MENLO PARK, CA, July 16 / MARKET WIRE/ -- SRI International researchers have found that the direct interaction between two neuropeptide systems -- hypocretins/orexins (Hcrt) and nociceptin/orphanin FQ (N/OFQ) -- is responsible for stress-induced blockage of pain.
2008-07-15 | EMax Health
Barriers To Effective Pain Management Still Remain In States
New report on pain management shows seven states have improved Pain Policies in the Last Year, but some barriers still remain. States continue to make steady progress in adopting balanced policies that help people with pain to alleviate their suffering, according to a report released today that evaluates...
2008-07-15 | Science Daily
Weeding Out The Highs Of Medical Marijuana
â Research exploring new ways of exploiting the full medicinal uses of cannabis while avoiding unwanted side-effects will be presented to pharmacologists on July 15 by scientists attending the Federation of European Pharmacological Societies Congress, EPHAR 2008.
2008-07-13 | Individual.com
Methadone deaths increase as its use as painkiller grows: Drug used to treat addiction relieves pain in high doses
(The News & Observer - McClatchy-Tribune Information Services via COMTEX) -- Methadone, long prescribed as an alternative to heroin, is proving to be a hazard of its own.
2008-07-12 | Pittsburgh Post-Gazette
Fibromyalgia patients fight insurers over medication coverage
With the Food and Drug Administration's approval of a second fibromyalgia medication last month, you'd think the nation's estimated 10 million acute pain fibromyalgia sufferers would be delighted.
2008-07-10 | Science Daily
New Surgical Option For Treating Diabetic And Other Neuropathies Being Tested
â UT Southwestern Medical Center plastic surgeons and specialists in diabetes, neurology, pain management and rehabilitation are launching a cutting-edge study of peripheral nerve surgery to alleviate long-standing pain and numbness in patients with diabetic neuropathy.
2008-07-10 | Consultant Live
Baby Boomers and Substance Abuse
An Emerging Issue Dr Trevisan is assistant clinical professor in the department of psychiatry at the Yale School of Medicine. He is certified in addiction and geriatric psychiatry and teaches in both the addiction and geriatric psychiatry fellowships at Yale University.
2008-07-10 | Medical News Today
APTA Endorses World Health Organization ICF Model
The American Physical Therapy Association (APTA) has joined the World Health Organization (WHO), the World Confederation for Physical Therapy, the American Therapeutic Recreation Association, and other international organizations in endorsing the WHO International Classification of Functioning, Disability,...
2008-07-09 | Bloomberg
KV Tablets Recalled in Canada Over Excess Morphine (Update3)
By Cristina Alesci July 9 (Bloomberg) -- Morphine tablets from generic-drug maker KV Pharmaceutical Co. are being recalled in Canada after some were found to contain too much of the painkiller.
2008-07-09 | Pharma Live
New Casa Report Finds: Most Web Sites Selling Prescription Opioids, Stimulants and Depressants Require No Prescription
SOME SITES NOW SELL PRESCRIPTIONS AND ONLINE MEDICAL CONSULTATIONS TO GET CONTROLLED DRUGS NEW YORK, July 9, 2008 Despite a decline in the number of Web sites advertising or selling controlled prescription drugs, like OxyContin and Valium, Xanax and Vicodin, and Ritalin and Adderall, in the past year, 85.
2008-07-09 | Medical News Today
Dopamine's Opposing Effects Separated By A Few Millimeters In The Brain
The chemical dopamine induces both desire and dread, according to new animal research in the July 9 issue of The Journal of Neuroscience. Although dopamine is well known to motivate animals and people to seek positive rewards, the study indicates that it also can promote negative feelings like fear.
2008-07-06 | American Medical News
New Medicare hospice rules aim to boost physicians' role
The most significant changes are designed to give patients more rights. Washington -- Medicare, for the first time in 25 years, has updated the rules for hospice physicians.
2008-07-05 | Modern Medicine
Treating pain without fear
Federal regulators are less suspicious of doctors who prescribe opioids for patients, but barriers to adequate treatment remain.
2008-07-03 | Doctors Guide
Use of rhBMP in Cervical Spine Fusion Linked to Life-Threatening Adverse Events
-- The US Food and Drug Administration (FDA) today informed healthcare professionals of reports of life-threatening complications associated with recombinant human Bone Morphogenetic Protein (rhBMP) when used in the cervical spine.
2008-07-02 | The Seattle Times
Medical marijuana proposal draws fire
Patients authorized to possess or grow marijuana for medical reasons under Washington law would be limited to 24 ounces of cultivated marijuana, six mature plants and 18 immature plants, according to a proposal filed by the state Department of Health Tuesday.
2008-07-01 | NewsOK.com
How daily doses of caffeine may battle multiple sclerosis
The same caffeine in your morning cup of coffee, afternoon soft drink or evening's chocolate ice cream dessert is being used by an Oklahoma City scientist to conquer the debilitating disease known as multiple sclerosis, or MS.
2008-07-01 | Earth Times
FDA Grants Conditional Approval to Interventional Spine's PercuDyn(TM) System IDE Application
IRVINE, Calif. - (Business Wire) Interventional Spine, Inc. announced today that the U.S. Food and Drug Administration has approved the Companys investigational device exemption (IDE) application for its PercuDyn System for the treatment of degenerative disc disease (DDD).
2008-07-01 | Pharma Live
XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
/PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. today announced that it has completed patient randomization into its Phase 2b study of Bicifadine -- a serotonin and norepinephrine reuptake inhibitor (SNRI) -- for the treatment of diabetic neuropathic pain.
2008-06-30 | MedPage Today
Numbing Spray Helps Relieve Cannulation Pain in Children
OTTAWA, June 30 -- A topical analgesic spray that cools and numbs the skin rapidly helps children deal with the pain associated with intravenous cannulation, a double-blind, randomized trial showed.
2008-06-30 | PR Newswire
Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel
Company's End-of-Phase II Meeting with FDA Set for Sept. 29 LA JOLLA, Calif., June 30 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that data presented at the 50th Annual Scientific Meeting of the American Headache Society showed that, in addition to meeting the primary...
2008-06-30 | Cincinnati Business Journal
Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
SOUTH SAN FRANCISCO, Calif., June 30 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that it has launched its first commercial product, Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system.
2008-06-30 | Medical News Today
Zogenix Announces Clinical Study Results For Sumatriptan DosePro, A Novel Migraine Treatment
Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that it will present successful results from two clinical studies of sumatriptan DosePro, a product in development for treatment of acute migraine and cluster headache, at the 50th Annual American Headache Society Meeting in...
2008-06-30 | Medical News Today
Scientists Research Use Of Electrical Stimulation To Make Artificial Limbs 'Feel' Real
Scientists are investigating whether by electrically stimulating the skin they can 'trick' the brain into making an artificial limb feel like a real part of the body, in the hope of improving the quality of amputees' lives.
2008-06-29 | American Medical News
AMA meeting: AMA OKs palliative sedation for terminally ill
The rarely employed practice of palliative or terminal sedation is sometimes perceived as speeding the dying process, leading critics to dub it a form of physician-assisted suicide.
2008-06-29 | Clinical Lab Products
Psychological stress activates complement cascade
NEW YORK (Reuters Health) - Acute stress increases complement cascade activation in healthy individuals, UK researchers have demonstrated, suggesting a mechanism by which stress could exacerbate inflammatory conditions.
2008-06-29 | Macro World Investor
Cape Fear Valley: Brain surgeon at work
AM Jun. 29--The first of two new neurosurgeons began seeing patients in Fayetteville last week, Cape Fear Valley Health System officials said. Dr. Richard Osenbach, who most recently worked as a neurosurgeon with Duke University Medical Center, was hired by the health system to work at its first surgical...
2008-06-29 | SmartBrief
LILLY (ELI) & COMPANY - Cymbalta GAD Positive Opinion from CHMP
Refer to: Charles McAtee (Eli Lilly and Company) +1 (317) 277-1566 Eva Freitag (Boehringer Ingelheim) + 49 (6132) 77-2964 European CHMP Issues Positive OpiniononCymbalta for the Treatment of Generalised Anxiety Disorder INDIANAPOLIS - June 27, 2008 - Eli Lilly and Co and Boehringer Ingelheim today announced..
2008-06-28 | Physical Therapy Products
Impliant Restarts European Clinical Activities for Patented TOPS(TM) Spine System
PRINCETON, N.J., June 26 /PRNewswire/ -- Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that it has resumed European clinical activities on its TOPS(TM) System, a Total Posterior Arthroplasty device designed to treat spinal stenosis with or without...
2008-06-27 | Immune Support
New Fibromyalgia Drug Trial Recruiting More Than 1,100 Subjects at 124 Locations in US and Canada
A major new trial of the drug reboxetine for Fibromyalgia pain and fatigue is now recruiting subjects at 124 locations in the US and Canada. [Note: Owing to the large number of study locations, trial organizers are now routing enquiries through a central 800 number.
2008-06-27 | PR Newswire via Yahoo!
Data Show Significantly More Patients Were Pain-Free with Treximet(TM) (sumatriptan and naproxen sodium) Tablets in the Acute Treatment of Probable Migraine Without Aura in Adults
Treximet was superior to placebo in producing pain-freedom at two hours and sustained pain-freedom from two through 24 hours BOSTON, June 27 /PRNewswire-FirstCall/ -- Patients suffering from probable migraine, which is defined as a sub-type of migraine that meets all but one of the migraine diagnostic...
2008-06-27 | HealthScout
Novel Treatments Ease Migraine Pain
THURSDAY, June 26 (HealthDay News) -- Technology may ease migraine and headache pain, two new studies suggest. 'What this tells us is that there are non-medical, non-drug treatments that are effective,' said Dr.
2008-06-27 | DiGiTAL50
Alkermes Initiates Phase 3 Clinical Study of VIVITROL(R) for the Treatment of Opioid Dependence
- Alkermes, Inc. (NASDAQ: ALKS) today announced the initiation of a phase 3 clinical trial of VIVITROL(R) (naltrexone for extended-release injectable suspension) for the treatment of opioid dependence.
2008-06-27 | Medical News Today
Alcohol Abuse More Common In Insured Patients, Drug Abuse In Uninsured
Fourteen percent of patients admitted to hospital have alcohol/drug abuse and addiction (ADAA) disorders, the costs for which have risen sharply in recent years, according to a study in the June issue of the Journal of Substance Abuse Treatment (JSAT).
2008-06-27 | Medical News Today
Drug Treatment Programs Influenced By State Policies
State policies have a significant impact on the services performed by substance abuse treatment programs, and could play a key role in efforts to expand the use of research-based "comprehensive" treatment approaches, reports a study in the June issue of the Journal of Substance Abuse Treatment (JSAT).
2008-06-27 | Science Daily
Marijuana May Be Effective For Neuropathic Pain
â The growing body of evidence that marijuana (cannabis) may be effective as a pain reliever has been expanded with publication of a new study in The Journal of Pain reporting that patients with nerve pain showed reduced pain intensity from smoking marijuana.
2008-06-26 | Healthcare Sales & Marketing Network
Applied Spine Technologies reports Stabilimax NZ(R) clinical trial milestone: enrollment surpasses 100 patients; 5 new sites added, boosting total to 21
Company's 'motion preserving' Stabilimax NZ(R) device is designed to treat one of the most common indications for spinal surgery: Lumbar Spinal Stenosis (LSS)NEW HAVEN, Conn.
2008-06-26 | News-Journal
Rheumatoid Arthritis Treatment Guidelines Updated
THURSDAY, June 26 (HealthDay News) -- New recommendations for the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA) have been developed by the American College of Rheumatology.
2008-06-25 | Pharma Live
Nerve Cells Derived from Embryonic Stem Cells and Transplanted into Mice May Lead to Improved Brain Treatments
- Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience.
2008-06-25 | Medical News Today
First Results For Phase IIa Data Of UCB's Lacosamide For Treatment Of Fibromyalgia
UCB announced headline results based on first-line analyses of its Phase IIa clinical trial with lacosamide to treat fibromyalgia syndrome. The initial results from this proof of concept study showed activity of lacosamide in fibromyalgia syndrome but require further analysis.
2008-06-25 | LifeNews.com
CALIFORNIA BILL PROMOTING EUTHANASIA GETS SENATE HEARING WEDNESDAY
Sacramento, CA (LifeNews.com) -- A bill in the California legislature that has already been approved by the state Assembly will get its first hearing in the Senate.
2008-06-25 | Pharmaceutical Executive
Biotech Watch: Dual Opiates, Certified Pigs
Just back from BIO, where two of the most interesting conversations I had were with companies from Down Under. First was Paul Tan, CEO of Living Cell Technologies, which is officially headquartered in Melbourne Australia, but operates out of Auckland, New Zealand.
2008-06-24 | Silo Breaker
Perspectives: Risks for Painkiller Abuse ...
Outweigh Benefits in Chronic Pain As controversy swirls about proper clinical use of opioids and other potent pain medications, research reported at the American Pain Society annual meeting shows that, contrary to widespread beliefs, less than three percent of patients with no history of drug abuse who are...
2008-06-24 | Scientific American
General Anesthesia: Sleep During Surgery, Wake up in Pain
Researchers studying the effects of general anesthesia recently made a startling discovery: the drugs used to knock out patients during surgery may lead to increased pain when they wake up.
2008-06-24 | TransWorldNews
Legalview Launches Pagcl Practice Area For Victims With Carti ...
Denver, CO - LegalView, the most comprehensive legal portal on the Web, recently announced the launch of its http://pagcl-pain-pump.legalview.com[pos t arthroscopic glenohumeral chondrolysis __title__ PAGCL] (PAGCL) practice area PAGCL is a severe and painful condition where shoulder cartilage begins to...
2008-06-24 | Red Orbit
Ancient Retrovirus May Contribute to Chronic Fatigue Syndrome, Multiple Sclerosis and Autoimmunity
Brigitte Huber, PhD, of the Tufts University School of Medicine, presented evidence at a medical conference that suggested that a reactivated ancient retrovirus embedded in the human genome may be active in chronic fatigue syndrome (CFS) and multiple sclerosis (MS) patients.
2008-06-24 | Pharmacist.com
Alvimopan approved to aid in restoration of bowel function - FDA has approved Entereg (Adolor; GlaxoSmithKline), a peripherally acting µ-opioid receptor antagonist, to accelerate the time to upper and lower gastrointestinal recovery following partia
Key point: FDA has approved alvimopan (Enteregâ⠬â Adolor; GlaxoSmithKline), a peripherally-acting à µ-opioid receptor antagonist, to accelerate the time to upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis in adult patients.
2008-06-24 | Free Press Release Center
Southern California's Top Drug and Alcohol Rehab Center Premiers an Innovative Opiate Addiction Treatment Program
Dana Point, California's SouthCoast Recovery drug and alcohol rehab center adds a Opiate specific treatment track program to its residential...
2008-06-24 | Medical News Today
Alexza Pharmaceuticals To Present AZ-104 Phase 2a Clinical Data At The American Headache Society Annual Scientific Meeting
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it will present results of its Phase 2a clinical trial of Staccato(R) loxapine (AZ-104) for the treatment of migraine headache at the 50th Annual Scientific Meeting of the American Headache Society, which being held at the Marriott Boston Copley...
2008-06-23 | Renal Business Today
Radiofrequency ID Devices May Pose Hazards to Medical Equipment
The use of radiofrequency identification devices appears to have the potential to cause anesthesia equipment, dialysis equipment and ventilator equipment to malfunction, as well as other medical devices, according to a study in the June 25 issue of JAMA.
2008-06-23 | Wal-Mart Watch
Illinois Doctors Warn Against In-Store Clinics
Wal-Marts recent announcement that it plans to introduce 400 new in-store health clinics over the next several years has raised concerns throughout the medical community.
2008-06-23 | NewsRX
Arthritis Clinical Trial - Study data from Harvard University update knowledge of arthritis clinical trial
New research, 'Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of ,' is the subject of a report. 'Rheumatoid (RA) is an characterized by joint , which if left untreated leads to progressive and joint destruction.
2008-06-22 | Clinical Lab Products
Aromatase inhibitors may relieve endometriosis-associated pain: review
NEW YORK (Reuters Health) - Aromatase inhibitors appear to be promising in alleviating pain, reducing lesion size and perhaps improving quality of life in women with painful endometriosis, researchers conclude based on a review of published studies.
2008-06-22 | Fredericksburg.com
Painkillers, heart drugs top list of common Rxs LAST YEAR'S TOP 10 Rxs
The top 10 most-prescribed drugs of 2007 shed light on America's health...
2008-06-21 | Asheville Citizen-Times
New Asheville clinic offers safer treatment of opioid addiction
ASHEVILLE A new clinic is making a safer alternative treatment for opioid addiction more widely available in Western North Carolina. Crossroads Treatment Center opened in April and specializes in treating people with suboxone, a drug approved by the Food and Drug Administration in 2002.
2008-06-20 | Pharma Live
YM BioSciences Announces FDA Lifts Clinical Hold on Aerolef and Clearance of a Phase II Clinical Trial
- Dr. Ali Raza To Lead Further Development Of AeroLEF As President Of AeroLEF Division - MISSISSAUGA, ON, June 19, 2008 /PRNewswire-FirstCall/ - YM BioSciences Inc.
2008-06-20 | Medical News Today
Aches? Pains? An Extra Dose Of Vitamin D May Provide Relief
Pain is the most common complaint leading patients to seek medical care and much of it is chronic, lasting 3 months or longer. According to an extensive review of clinical research in a new report from Pain Treatment Topics, inadequate vitamin D intake has been linked to a long list of chronic painful...
2008-06-20 | Medical News Today
Report On Presentations From The European Society For The Study Of Interstitial Cystitis (ESSIC) Annual Meeting
BERKELEY, CA (UroToday.com) - This year's meeting was held in Rome, Italy from June 5-7, 2008. In just a few short years, the meeting of the ESSIC group has expanded dramatically.
2008-06-19 | News Blaze
Hospice Programs Nationwide Urge Congress to Act on Behalf of End-of Life Patients
Millions affected as Administration proposes $2.29 billion hospice rate cut WASHINGTON, June 19 /PRNewswire-USNewswire/ -- More than 3,500 individual hospice providers representing all 50 states are calling on Congress to take immediate action to stop the Administration from slashing the hospice...
2008-06-18 | NYC Independent Media Center
N.Y. Assembly Passes Medical Marijuana Bill
ALBANY, NEW YORK - The New York Assembly passed a bill today that would protect New Yorkers with life threatening or debilitating conditions from arrest for using medical marijuana when their doctors believe it would be the best treatment option, 79-48.
2008-06-18 | WROC TV
Rochester doctors examine new drugs to treat back pain
John Bleier of Greece has a big task ahead of him; he's supervising the remodeling of part of St. Matthew's Lutheran Church in Rochester. he's struggled with lower back pain or spinal stenosis for years.
2008-06-18 | FDA News
Transdel Initiates Ketotransdel Phase III Trial for Pain
RxTrials Institute Drug Pipeline Alert Transdel Pharmaceuticals has begun a Phase III clinical trial for Ketotransdel, its novel topical cream-based, nonsteroidal, anti-inflammatory drug for pain.
2008-06-17 | PrimeNewswire via Yahoo!
Acurox Tablets Meet Primary Endpoint in Pivotal Phase III Study
(PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (NasdaqCM:ACUR - News) and King Pharmaceuticals, Inc. (NYSE:KG - News) today announced positive top-line results from Acura's pivotal Phase III study, AP-ADF-105 (''Study 105'').
2008-06-17 | Medical News Today
FDA Approves Cymbalta(R) For The Management Of Fibromyalgia
The U.S. Food and Drug Administration (FDA) has approved Cymbalta(R) (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company (NYSE: LLY) announced.
2008-06-11 | Health.com
Chronic Painand Sex: Howto stay intimate
Chronic Pain News and Insights Sign up for a free weekly email with our most up-to-date information. How People in Pain Can Revive Their Sex Lives Email You don't have to accept the loss of a sex life when you're in pain.

AAPM's 25th Annual Meeting:Hawaii 2009

Register Online Now!

Register Online By October 31st and get chance to win 2 free nights at Hilton Hawaiian Village
> Register Now

Scientific Poster Abstract

Deadline Extended to September 1st
> More Info

New Position Statements

AAPM Supports:

Safe Controlled Substance Practices
> More Info

Spinal Cord Stimulation
> Read More

Members Take Action

Watch for AAPM and AMA survey
> Read More

Support Pain Care for Our Troops
> Read More



New Board Announced

New Board of Directors for 2008-2009 is now in place...

> Read More

Plan Now for Hawaii

Celebrate AAPM's 25th Anniversary in Hawaii. Jan. 28-31, 2009. Essentials of Pain 2Day Course & Precon Workshops start Jan. 27th. Register now!

> Read More

Publications

journal image AAPM's award-winning publications are devoted to the advancement of pain management, education and research.

> Read More

American Board of Pain Medicine

This psychometrically developed,practice-related examination in Pain Medicine...

> Read More